CN Stock MarketDetailed Quotes
300972 Fujian Wanchen Biotechnology Group
- 79.20
- +0.92+1.18%
Market Closed Jan 10 15:00 CST
14.26BMarket Cap246.73P/E (TTM)
79.97High76.83Low17.70KlotVolume78.50Open78.28Pre Close139.96MTurnover1.14%Turnover RatioLossP/E (Static)179.99MShares84.4352wk High15.56P/B12.34BFloat Cap17.6952wk Low93.94Limit Up155.76MShs Float84.43Historical High62.62Limit Down4.01%Amplitude10.19Historical Low--Dividend TTM79.06Avg Price8.25KlotAsk--Div YieldTTM100Lot Size8.24KlotBid
Fujian Wanchen Biotechnology Group Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 315.04%23.22B | 397.43%12.24B | 567.79%5.4B | 1,810.87%10.64B | 1,456.42%5.59B | 1,097.99%2.46B | 576.83%808.87M | 34.28%557.07M | 41.54%359.38M | 25.06%205.35M |
| Cash received relating to other operating activities | 265.59%598.96M | 429.01%580.78M | 289.33%140.8M | 2,602.28%1.07B | 528.86%163.83M | 465.62%109.79M | 98.94%36.16M | 6.25%39.5M | -26.86%26.05M | -40.16%19.41M |
| Cash inflows from operating activities | 313.63%23.81B | 398.78%12.82B | 555.87%5.54B | 1,863.27%11.71B | 1,393.73%5.76B | 1,043.38%2.57B | 513.74%845.03M | 31.98%596.57M | 33.12%385.44M | 14.30%224.76M |
| Goods services cash paid | 318.64%21.52B | 400.97%11.19B | 602.90%4.9B | 2,310.76%9.46B | 2,250.03%5.14B | 1,573.36%2.23B | 957.90%697.82M | 54.87%392.42M | 30.43%218.76M | 25.91%133.53M |
| Staff behalf paid | 119.48%572.45M | 143.94%324.09M | 220.76%156.47M | 285.22%401.88M | 251.27%260.82M | 169.55%132.86M | 97.91%48.78M | 19.71%104.33M | 13.86%74.25M | 12.86%49.29M |
| All taxes paid | 717.00%405.76M | 869.02%241M | 977.37%103.88M | 933.15%93.11M | 515.17%49.67M | 238.57%24.87M | 316.57%9.64M | 158.27%9.01M | 230.07%8.07M | 359.26%7.35M |
| Cash paid relating to other operating activities | -6.88%341.56M | 167.69%503.28M | 70.41%101.02M | 3,492.47%733.75M | 3,627.93%366.81M | 4,057.06%188.01M | 2,928.35%59.28M | 122.55%20.42M | 10.42%9.84M | -10.28%4.52M |
| Cash outflows from operating activities | 292.59%22.84B | 375.25%12.26B | 545.76%5.27B | 1,931.44%10.69B | 1,771.27%5.82B | 1,225.29%2.58B | 759.51%815.52M | 48.97%526.19M | 27.27%310.93M | 24.51%194.68M |
| Net cash flows from operating activities | 1,696.18%972.48M | 5,530.95%556.21M | 835.22%275.97M | 1,353.60%1.02B | -181.77%-60.93M | -134.05%-10.24M | -31.06%29.51M | -28.78%70.38M | 64.72%74.51M | -25.33%30.08M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | ---- | ---- | -99.98%3.06K | ---- | --20.01M | --20M | --20M |
| Cash received from returns on investments | -99.89%66.74 | ---- | ---- | -96.43%62.63K | -95.98%62.63K | -95.11%62.63K | -92.46%62.63K | -0.99%1.76M | --1.56M | --1.28M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 724.26%16.78M | 73.63%17.14M | 536.12%1.92M | 4,736.10%17.55M | 573.82%2.04M | 3,464.69%9.87M | 835.78%301.32K | -1.46%362.95K | -0.74%302.14K | 80.14%276.88K |
| Cash inflows from investing activities | 699.66%16.78M | 72.49%17.14M | 426.65%1.92M | -20.40%17.62M | -90.40%2.1M | -53.91%9.94M | -99.82%363.95K | 933.18%22.13M | 7,081.02%21.86M | 13,926.62%21.56M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -24.89%93.36M | -15.26%67.69M | 45.82%48.56M | -30.80%218.91M | -32.94%124.3M | 16.98%79.88M | -7.80%33.3M | 660.92%316.34M | 463.47%185.35M | 224.93%68.29M |
| Cash paid to acquire investments | --294M | ---- | ---- | ---- | ---- | -99.99%3.06K | ---- | -99.95%10K | --30M | --60M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | --5.4M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | --1.2 | ---- | ---- | ---- |
| Cash outflows from investing activities | 211.64%387.36M | -15.27%67.69M | 45.82%48.56M | -29.10%224.3M | -42.28%124.3M | -37.73%79.89M | -90.09%33.3M | 413.78%316.35M | 554.68%215.35M | 510.43%128.29M |
| Net cash flows from investing activities | -203.26%-370.58M | 27.73%-50.55M | -41.61%-46.64M | 29.75%-206.69M | 36.85%-122.2M | 34.46%-69.95M | 75.65%-32.94M | -395.06%-294.22M | -493.72%-193.49M | -411.59%-106.73M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | 2,978.24%295.63M | 5,278.68%253.01M | 8,551.29%195M | 106.60%21.5M | 150.10%9.6M | --4.7M | --2.25M | -95.76%10.41M | -98.35%3.84M | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | 15.84%12.05M | 150.10%9.6M | --4.7M | --2.25M | --10.41M | --3.84M | ---- |
| Cash from borrowing | 81.61%778.77M | 131.26%422.57M | 58.64%252.77M | 124.92%598.22M | 302.24%428.82M | 146.50%182.73M | 322.64%159.34M | 193.24%265.97M | 50.37%106.61M | 4.56%74.13M |
| Cash received relating to other financing activities | ---- | ---- | ---- | --15M | ---- | --15M | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 145.06%1.07B | 233.74%675.59M | 177.10%447.77M | 129.66%634.72M | 296.95%438.43M | 173.08%202.43M | 328.62%161.59M | -17.77%276.37M | -63.67%110.45M | -76.56%74.13M |
| Borrowing repayment | 299.44%371.63M | 160.09%176.46M | 98.55%109.2M | 104.81%195.69M | 24.22%93.04M | 13.27%67.85M | 10.00%55M | -45.48%95.55M | -49.82%74.9M | -51.21%59.9M |
| Dividend interest payment | 137.63%26M | 126.41%14.11M | 149.63%6.53M | -61.36%15.15M | -70.02%10.94M | -82.49%6.23M | 194.11%2.61M | 649.16%39.22M | 769.10%36.49M | 1,124.29%35.59M |
| Cash payments relating to other financing activities | 568.82%221.72M | 43.40%91.5M | 881.40%67.59M | 964.11%201.62M | 157.67%33.15M | 141,912.03%63.8M | 30,557.19%6.89M | 53.47%18.95M | --12.87M | -99.38%44.93K |
| Cash outflows from financing activities | 351.66%619.35M | 104.57%282.06M | 184.20%183.31M | 168.34%412.46M | 10.36%137.13M | 44.33%137.88M | 26.70%64.5M | -20.29%153.71M | -19.03%124.26M | -28.10%95.53M |
| Net cash flows from financing activities | 51.03%455.06M | 509.64%393.52M | 172.39%264.46M | 81.20%222.26M | 2,282.41%301.3M | 401.61%64.55M | 834.99%97.09M | -14.39%122.66M | -109.17%-13.81M | -111.67%-21.4M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---- | ---- | ---- | ---146.76 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net increase in cash and cash equivalents | 794.40%1.06B | 5,847.77%899.18M | 427.21%493.79M | 1,126.60%1.04B | 189.00%118.17M | 84.05%-15.64M | 188.64%93.66M | -155.39%-101.17M | -181.34%-132.79M | -148.33%-98.05M |
| Add:Begin period cash and cash equivalents | 902.89%1.15B | 902.89%1.15B | 902.89%1.15B | -46.79%115.04M | -46.79%115.04M | -46.79%115.04M | -46.79%115.04M | 544.65%216.21M | 544.65%216.21M | 544.65%216.21M |
| End period cash equivalent | 847.92%2.21B | 1,965.42%2.05B | 689.41%1.65B | 902.89%1.15B | 179.55%233.21M | -15.88%99.39M | 88.78%208.7M | -46.79%115.04M | -57.61%83.42M | -50.02%118.16M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
